Revvity to acquire Human Cell Design
Engineered immune cells trial to fight colorectal cancer approved
Elix and Axcelead DDP to collaborate on targeted protein degrader discovery
Lotus Neuro launches to deliver therapies across blood-brain barrier
New research could lead to vaccine for severe diarrhoea
BioArctic and Lilly sign research agreement
Biogen boosts immunology pipeline through $1bn RayThera acquisition
Brain tau spreads differently in early- and late-onset Alzheimer’s disease
Base to Base biotech podcast 65: Giving medicine a genetic camouflage
Vedana Therapeutics launches to develop migraine therapies
Memento Medicines launches with $93m to develop antibody therapy for retinal diseases
Meteor Biotech joins brain organoids consortium